{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:51:54Z","timestamp":1784069514744,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009577.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000}}],"reference-count":75,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009577.pub3","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T13:40:40Z","timestamp":1436881240000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Long-acting FSH versus daily FSH for women undergoing assisted reproduction"],"prefix":"10.1002","volume":"2016","author":[{"given":"Annefloor W","family":"Pouwer","sequence":"first","affiliation":[{"name":"Rijnstate Hospital; Department of Gynaecology and Obstetrics; Wagnerlaan 55 PO Box 9555 Arnhem Netherlands 6800 TA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Farquhar","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Obstetrics and Gynaecology; FMHS Park Road Grafton Auckland New Zealand 1003"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan AM","family":"Kremer","sequence":"additional","affiliation":[{"name":"Radboud University Nijmegen Medical Center; Department of Obstetrics and Gynaecology; PO Box 9101 Nijmegen Netherlands 6500 HB"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD009577.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1210\/jc.2003-031766","article-title":"Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization","volume":"89","author":"Devroey","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0002|cit2","unstructured":"NCT00702195 Pregnancy and neonatal follow-up of ongoing pregnancies established during phase II clinical trials for the development of Org 36286 (corifollitropin alfa) clinicaltrials.gov\/show\/NCT00702195"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0003|cit3","unstructured":"NCT00702195 Pregnancy and neonatal follow-up of ongoing pregnancies established during phase II clinical trials for the development of Org 36286 (corifollitropin alfa) www.clinicalstudyresults.org"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0004|cit4","unstructured":"NCT00702806 A phase III, open-label, prospective, randomized, comparative clinical trial to investigate the appropriate dose of a single injection of Org 36286 (corifollitropin alfa) to initiate multiple follicular growth in a controlled ovarian hyperstimulation protocol for IVF or IVF\/ICSI clinicaltrials.gov\/show\/NCT00702806"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0005|cit5","unstructured":"NCT00702806 A phase III, open-label, prospective, randomized, comparative clinical trial to investigate the appropriate dose of a single injection of Org 36286 (corifollitropin alfa) to initiate multiple follicular growth in a controlled ovarian hyperstimulation protocol for IVF or IVF\/ICSI www.clinicalstudyresults.org"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0006|cit6","unstructured":"Behr B Heijnen E Corifollitropin alfa versus recombinant FSH treatment for COS in a GnRH antagonist protocol: equal efficacy in terms of oocyte and embryo quality Human Reproduction, European Society of Human Reproduction and Embryology, ESHRE 25th Annual Meeting; 2009 June 28-July 1 2009; Amsterdam, The Netherlands 2009"},{"issue":"7","key":"10.1002\/14651858.CD009577.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/humrep\/des156","article-title":"Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome","volume":"27","author":"Bonduelle","year":"2012","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0008|cit8","unstructured":"Boostanfar R Devroey P Oberye J Mannaerts B No difference in the cumulative pregnancy rates or live birth rates when comparing corifollitropin alfa with daily rFSH treatment for COS Human Reproduction. Abstracts of the 26th Annual Meeting of ESHRE; 2010 June 27-30; Rome 2010 i47 Abstract no. O-119"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD009577.pub3-BIB0009|cit9","first-page":"174","article-title":"International differences in IVF live birth rates and ongoing pregnancy rates following ovarian stimulation with corifollitropin alfa or recombinant FSH","volume":"96","author":"Boostanfar","year":"2011","journal-title":"Fertility and Sterility, Annual Meeting of the American Society for Reproductive Medicine. 2011 Oct 15-19; Orlando"},{"issue":"5","key":"10.1002\/14651858.CD009577.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/humrep\/deu030","article-title":"Erratum: A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"29","author":"Devroey","year":"2014","journal-title":"Human Reproduction"},{"issue":"12","key":"10.1002\/14651858.CD009577.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0012|cit12","unstructured":"Fatemi HM Doody K Witjes H Mannaerts B A high ovarian response does not compromise the change of pregnancy Human Reproduction, 27th Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE Stockholm, Sweden 2011 i319 Abstract no. P-510"},{"issue":"5","key":"10.1002\/14651858.CD009577.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rbmo.2010.06.032","article-title":"Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF","volume":"21","author":"Fauser","year":"2010","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0014|cit14","unstructured":"Fernandez Sanchez M Koper N Equally high ongoing pregnancy rates with corifollitropin alfa and recombinant FSH irrespective of variations in ART procedures Human Reproduction, Abstracts of the 26th Annual Meeting of ESHRE; 2009 June 28-July 1; Amsterdam, The Netherlands 2009 i2 O-005 Oral"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0015|cit15","unstructured":"Hillensjo T Yeko T Witjes H Elbers J Devroey P Does treatment flexibility affect clinical outcome of either corifollitropin alfa or daily regimens? Human Reproduction, 27th Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE Stockholm, Sweden 2011 i303-4 Abstract no. P468"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0016|cit16","unstructured":"Leader A Pang S Witjes H Gordon K Devroey P Reduction of daily rFSH dose from stimulation day 8 onward in a corifollitropin alfa or rFSH treatment regimen does not compromise clinical outcome Human Reproduction, 27th Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE Stockholm, Sweden 2011 i302 Abstract no. P-465"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0017|cit17","unstructured":"NCT00698800 A phase III, non-inferiority clinical trial to investigate the efficacy and safety of a single injection of 150 \u03bcg Org 36286 (corifollitropin alfa) to induce multifollicular development for ovarian stimulation using daily recombinant FSH as reference clinicaltrials.gov\/show\/NCT00698800"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0018|cit18","unstructured":"NCT00698800 A phase III, randomised, double-blind, active-controlled, non-inferiority clinical trial to investigate the efficacy and safety of a single injection of 150 \u03bcg Org 36286 (corifollitropin alfa) to induce multifollicular development for ovarian stimulation using daily recombinant FSH as reference www.clinicalstudyresults.org"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0019|cit19","unstructured":"NCT00702273 Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 38819 clinicaltrials.gov\/show\/NCT00702273"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0020|cit20","unstructured":"NCT00702273 Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 38819 www.clinicalstudyresults.org"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0021|cit21","unstructured":"NCT00703014 Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in Clinical Trial 38819 (P05787) for ORG 36286 (Corifollitropin alfa) www.clinicalstudyresults.org"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0022|cit22","unstructured":"NCT00703014 Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in Clinical Trial 38819 for ORG 36286 (Corifollitropin alfa) clinicaltrials.gov\/show\/NCT00703014"},{"issue":"7","key":"10.1002\/14651858.CD009577.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/humrep\/des156","article-title":"Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome","volume":"27","author":"Bonduelle","year":"2012","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD009577.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","article-title":"Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women","volume":"21","author":"Schenk","year":"2010","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0025|cit25","unstructured":"Hillenjso T Von Mauw E A comparison of corifollitropin vs. recombinant FSH in a GnRH antagonist protocol for controlled ovarian stimulation in women weighing 60 kg or less Human Reproduction. European Society of Human Reproduction and Embryology, ESHRE 25th Annual Meeting; 2009 June 28-July 1; Amsterdam 2009 i2"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0027|cit26","unstructured":"NCT00702546 Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 107012 clinicaltrials.gov\/show\/NCT00702546"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0026|cit27","unstructured":"NCT00702546 Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 107012 (P05711) www.clinicalstudyresults.org (accessed November 2009)"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0029|cit28","unstructured":"NCT00702624 Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 107012 for the development of Org 36286 (corifollitropin alfa) clinicaltrials.gov\/show\/NCT00702624"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0028|cit29","unstructured":"NCT00702624 Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 107012 for the development of Org 36286 (corifollitropin alfa) (107014\/P05710) www.clinicalstudyresults.org"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0030|cit30","unstructured":"NCT00702845 A phase III, equivalence clinical trial to investigate the efficacy and safety of a single injection of 100 \u03bcg Org 36286 (Corifollitropin alfa) to induce multifollicular development for ovarian stimulation using daily recombinant FSH as reference clinicaltrials.gov\/show\/NCT00702845"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0031|cit31","unstructured":"NCT00702845 A phase III, randomized, double-blind, active-controlled, equivalence clinical trial to investigate the efficacy and safety of a single injection of 100 \u03bcg Org 36286 (Corifollitropin alfa) to induce multifollicular development for controlled ovarian stimulation (COS) using daily recombinant FSH (rFSH) as a reference www.clinicalstudyresults.org"},{"issue":"11","key":"10.1002\/14651858.CD009577.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/humrep\/den288","article-title":"A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation","volume":"23","author":"Anderson","year":"2008","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0033|cit33","unstructured":"NCT005982088 A phase 2, open label, randomized trial to investigate the dose-response relationship of a single injection or Org 36286 (corifollitropin alfa) to initiate multiple follicular growth in a controlled ovarian hyperstimulation protocol for IVF or ICSI clinicaltrials.gov\/show\/NCT005982088"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0034|cit34","unstructured":"NCT005982088 A phase 2, open label, randomized trial to investigate the dose-response relationship of a single injection or Org 36286 (corifollitropin alfa) to initiate multiple follicular growth in a controlled ovarian hyperstimulation protocol for IVF or ICSI www.clinicalstudyresults.org"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0035|cit35","unstructured":"NCT00702988 Pregnancy and neonatal follow-up of ongoing pregnancies established during a previous clinical trial for the development of Org 36286 (corifollitropin alfa) (38827\/P06056) www.clinicalstudyresults.org"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0036|cit36","unstructured":"NCT00702988 Pregnancy and neonatal follow-up of ongoing pregnancies established during clinical trial 38826 for the development of Org 36286 (corifollitropin alfa) clinicaltrials.gov\/show\/NCT00702988"},{"issue":"6","key":"10.1002\/14651858.CD009577.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.fertnstert.2012.02.038","article-title":"A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone","volume":"97","author":"Boostanfar","year":"2012","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1016\/j.fertnstert.2011.07.680","article-title":"International differences in IVF live birth rates and cumulative ongoing pregnancy rates following ovarian stimulation with corifollitropin alfa or recombinant FSH","volume":"1","author":"Boostanfar","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009577.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.fertnstert.2012.07.125","article-title":"A large double-blind efficacy and safety trial of corifollitropin alfa versus daily recombinant FSH in women 35 to 42 years of age undergoing ovarian stimulation prior to IVF or ICSI (pursue trial)","volume":"98","author":"Boostanfar","year":"2012","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0040|cit40","unstructured":"NCT01144416 A Phase III, Randomized, Double-blind, Active-controlled, Non-inferiority Trial to Investigate the Efficacy and Safety of a single injection of SCH 900962 (Corifollitropin alfa) to Induce Multifollicular Development for Controlled Ovarian Stimulation (COS) Using Daily Recombinant FSH (recFSH) as a Reference in Women aged 35-42 Years (P06029) clinicaltrials.gov\/show\/ NCT01144416"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0041|cit41","unstructured":"NCT01144416 Efficacy and safety study of a single injection of SCH 900962 versus daily recFSH injections in women undergoing controlled ovarian stimulation (study P06029 AM1) (PURSUE) clinicaltrials.gov\/show\/NCT01144416"},{"issue":"3","key":"10.1002\/14651858.CD009577.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.fertnstert.2013.07.1863","article-title":"Incidence of congenital malformations after ovarian stimulation with corifollitropin alfa or recombinant FSH: Data from 3 randomized controlled trials","volume":"100","author":"Stegmann","year":"2013","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0043|cit43","unstructured":"NCT01319695 Corifollitropin alfa versus recombinant follicle stimulating hormone (FSH) in ovarian stimulation of women undergoing in vitro fertilisation clinicaltrials.gov\/show\/NCT01319695"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0044|cit44","doi-asserted-by":"crossref","unstructured":"Sioulas V Siristatidis C Chrelias C Alexiou E Vrantza T Kassanos D Corifollitropin alfa vs. recombinant follicle stimulating hormone in ovarian stimulation of women undergoing in vitro fertilization: Preliminary results Fertility and Sterility 2011 S181 P-252","DOI":"10.1016\/j.fertnstert.2011.07.705"},{"issue":"12","key":"10.1002\/14651858.CD009577.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1210\/jc.2004-0668","article-title":"Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility","volume":"89","author":"Balen","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD009577.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/11206890-000000000-00000","article-title":"Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction","volume":"25","author":"Croxtall","year":"2011","journal-title":"BioDrugs"},{"issue":"8","key":"10.1002\/14651858.CD009577.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1358\/dot.2011.47.8.1635872","article-title":"Corifollitropin alfa: a new option to treat female infertility","volume":"47","author":"Lartigue","year":"2011","journal-title":"Drugs of Today"},{"issue":"5","key":"10.1002\/14651858.CD009577.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.fertnstert.2009.12.070","article-title":"Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial","volume":"94","author":"Fatemi","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1477-7827-11-52","article-title":"Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial","volume":"11","author":"Leader","year":"2013","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009577.pub3-BIB0050|cit50","first-page":"i114","article-title":"On behalf on the ENGAGE\/ENSURE investigators: Two doses of corifollitropin alfa allow for similar exposure and ovarian response in patients weighing \u226460 kg and >60 kg","volume":"24","author":"Ledger","year":"2009","journal-title":"Molecular Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD009577.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/WHE.10.56","article-title":"Corifollitropin alfa: a novel long-acting recombinant follicle-stimulating hormone agonist for controlled ovarian stimulation","volume":"6","author":"Loutradis","year":"2010","journal-title":"Women's Health"},{"issue":"4","key":"10.1002\/14651858.CD009577.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.fertnstert.2012.01.092","article-title":"Is there a place for corifollitropin alfa in IVF\/ICSI cycles? A systematic review and meta-analysis","volume":"97","author":"Mahmoud Youssef","year":"2012","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD009577.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/humrep\/der163","article-title":"Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity","volume":"26","author":"Norman","year":"2011","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD009577.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/eog.11.36","article-title":"Corifollitropin alfa: A new recombinant FSH gonadotropin analogue","volume":"6","author":"Prados","year":"2011","journal-title":"Expert Review of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD009577.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1517\/14712598.2012.641530","article-title":"Corifollitropin alfa for female infertility","volume":"12","author":"Rombauts","year":"2012","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0056|cit56","first-page":"243","article-title":"The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist","volume":"3","author":"Seyhan","year":"2011","journal-title":"International Journal of Women's Health"},{"issue":"Supplement 3","key":"10.1002\/14651858.CD009577.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.fertnstert.2013.07.175","article-title":"Is longer better? The long and short of it - a matched case control study of long and short acting follicle stimulating hormone","volume":"100","author":"Talmor","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD009577.pub3-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001750.pub3","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009577.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/clpt.2010.54","article-title":"Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation","volume":"88","author":"Greef","year":"2010","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD009577.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Human Reproduction"},{"issue":"8","key":"10.1002\/14651858.CD009577.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/humrep\/17.8.1987","article-title":"Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females","volume":"17","author":"Duijkers","year":"2002","journal-title":"Human Reproduction"},{"issue":"9327","key":"10.1002\/14651858.CD009577.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(02)09417-5","article-title":"Female subfertility","volume":"360","author":"Evers","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD009577.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn065","article-title":"Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency","volume":"15","author":"Fauser","year":"2009","journal-title":"Human Reproduction Update"},{"issue":"5","key":"10.1002\/14651858.CD009577.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/humrep\/deh870","article-title":"Definition and prevalence of subfertility and infertility","volume":"20","author":"Gnoth","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0065|cit65","volume-title":"Obstetrie en Gynaecology. De voortplanting van de mens","author":"Heineman","year":"2007"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0066|cit66","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0067|cit67","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511894756","volume-title":"How to Improve your ART Success Rates. An Evidence-Based Review of Adjuncts to IVF","author":"Kovacs","year":"2011"},{"issue":"8","key":"10.1002\/14651858.CD009577.pub3-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006919.pub3","article-title":"Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction","author":"Maheshwari","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0069|cit69","unstructured":"Farquhar C Clarke J Lethaby A Thomas J Proctor M Barlow D Cochrane Menstrual Disorders and Subfertility Group, About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) Available at www.thecochranelibrary.com 2008"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0070|cit70","unstructured":"The Nordic Cochrane Centre, the Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"5","key":"10.1002\/14651858.CD009577.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1472-6483(10)61110-8","article-title":"Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients","volume":"8","author":"Schr\u00f6der","year":"2004","journal-title":"Reproductive Biomedicine Online"},{"issue":"1","key":"10.1002\/14651858.CD009577.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bpobgyn.2006.08.002","article-title":"GnRH agonists vs antagonists","volume":"21","author":"Tarlatzis","year":"2007","journal-title":"Best Practice & Research. Clinical Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD009577.pub3-BIB0073|cit73","unstructured":"Tur-Kaspa I Fauser B The use of GnRH agonist in IVF protocols IVF Worldwide website http:\/\/www.ivf worldwide.com\/survey\/the-use-of-gnrh-agonist-in-ivf-protocols\/results-the-use-of-gnrh-agonist-in-ivf-protocols.html"},{"issue":"1","key":"10.1002\/14651858.CD009577.pub3-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009577","article-title":"Long-acting FSH versus daily FSH for women undergoing assisted reproduction","author":"Pouwer","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009577.pub3-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009577.pub2","article-title":"Long-acting FSH versus daily FSH for women undergoing assisted reproduction","author":"Pouwer","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009577.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T06:32:07Z","timestamp":1691735527000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009577.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":75,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009577.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]}}}